The Los Angeles area-based AIDS ReSearch Alliance Of America on Thursday announced the beginning of Phase I human trials of an experimental preventive HIV vaccine. Initial injections of the vaccine were given to the first project volunteer at a press conference held in West Hollywood, Calif. The vaccine aims to create HIV antibodies and other cellular immunity to the virus so that HIV is quickly targeted and destroyed when it enters the body. The Phase I test, which is designed to prove that the vaccine is safe, will last five years. Efficacy tests will follow.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved















